COM:CYTOMX
CytomX Therapeutics
- Stock
Last Close
0.99
31/10 18:08
Market Cap
102.07M
Beta: -
Volume Today
288.05K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 100K - | 50K 50% | ||||||||||
average payables | 1.42M - | 3.31M 132.22% | 5.65M 70.69% | 5.40M 4.36% | 4.67M 13.55% | 4.64M 0.50% | 3.58M 22.99% | 2.91M 18.73% | 2.81M 3.22% | 2.13M 24.17% | ||
average receivables | 1.06M - | 1.31M 24.01% | 1.53M 16.72% | 6.23M 307.33% | 5.12M 17.80% | 55K 98.93% | 405.50K 637.27% | 794K 95.81% | 18.39M 2,215.87% | 19.71M 7.18% | ||
book value per share | -1.27 - | -2.25 77.38% | 14.67 752.20% | 2.17 85.23% | 1.88 13.17% | 3.14 67.04% | 1.13 64.11% | 1.08 4.27% | 1.39 29.10% | -1.30 193.62% | -0.00 99.95% | |
capex per share | -0.02 - | -0.05 127.19% | -0.19 289.47% | -0.06 67.62% | -0.04 30.15% | -0.09 116.75% | -0.08 15.16% | -0.05 35.13% | -0.03 49.87% | -0.03 5.52% | -0.00 99.96% | |
capex to depreciation | -1.12 - | -2.12 90.05% | -1.32 37.77% | -1.26 5.00% | -0.95 24.52% | -2.01 112.15% | -1.34 33.23% | -0.90 33.15% | -0.59 33.74% | -0.71 19.78% | -5.75 707.79% | |
capex to operating cash flow | 0.09 - | -0.05 157.21% | 0.06 211.19% | 1.07 1,741.77% | -0.01 100.85% | 0.05 648.15% | 0.02 50.37% | -0.44 1,863.76% | 0.01 103.08% | 0.02 16.19% | 0.01 4.55% | |
capex to revenue | -0.82 - | -0.33 60.26% | -0.21 36.90% | -0.14 30.02% | -0.02 84.95% | -0.06 192.47% | -0.06 4.45% | -0.02 62.18% | -0.02 0.52% | -0.03 41.52% | -0.01 74.64% | |
cash per share | 0.25 - | 1.84 639.93% | 21.72 1,078.11% | 5.02 76.89% | 10.07 100.47% | 10.47 3.99% | 6.53 37.60% | 6.85 4.87% | 4.76 30.54% | 2.95 38.09% | 0.00 99.92% | |
days of inventory on hand | ||||||||||||
days payables outstanding | ||||||||||||
days sales outstanding | 97.42 - | 134.80 38.38% | 35.21 73.88% | 56.12 59.38% | 51.67 7.93% | 0.60 98.85% | 0.08 86.13% | 2.90 3,416.21% | 4.14 42.81% | 247.07 5,861.26% | 12.38 94.99% | |
debt to assets | 0.30 - | 0.04 86.20% | 0.03 - | 0.08 177.95% | 0.07 14.51% | 0.06 7.91% | 0.07 8.39% | 0.07 0.05% | ||||
debt to equity | -0.09 - | -0.04 59.93% | 0.10 - | 0.54 431.39% | 0.50 7.79% | 0.24 51.44% | -0.21 186.84% | -0.29 39.86% | ||||
dividend yield | 0.04 - | |||||||||||
earnings yield | -0.03 - | -0.07 100.16% | -0.20 193.12% | -0.15 25.00% | -0.05 62.86% | -0.13 144.81% | -0.27 101.80% | -0.11 59.91% | -0.29 166.87% | -0.93 218.59% | -0.00 100.00% | |
enterprise value | 446.03M - | 389.12M 12.76% | 119.56M 69.27% | 293.57M 145.54% | 607.04M 106.78% | 381.56M 37.15% | 213.19M 44.13% | 135.26M 36.55% | 90.28M 33.26% | -70.41M 177.99% | 114.40B 162,578.04% | |
enterprise value over ebitda | -31.36 - | -13.40 57.25% | -3.69 72.49% | -5.29 43.47% | -13.61 157.22% | -5.02 63.10% | -1.92 61.71% | -2.94 52.85% | -1.08 63.33% | 0.69 164.48% | -17.64K 2,539,383.22% | |
ev to operating cash flow | -55.70 - | 12.24 121.97% | -4.36 135.64% | -144.48 3,212.79% | 3.56 102.47% | -5.05 241.80% | -1.52 69.96% | 25.72 1,794.86% | -0.76 102.95% | 0.64 183.79% | -2.04K 321,338.82% | |
ev to sales | 502.29 - | 76.64 84.74% | 15.50 79.77% | 19.52 25.88% | 8.48 56.57% | 6.41 24.34% | 3.71 42.17% | 1.35 63.66% | 1.30 3.72% | -1.32 202.06% | 1.13K 85,442.15% | |
free cash flow per share | -0.25 - | 0.86 444.84% | -3.38 491.09% | -0.12 96.56% | 4.54 4,011.13% | -1.90 141.91% | -3.18 66.84% | 0.06 102.01% | -1.88 3,041.87% | -1.71 8.98% | -0.00 99.95% | |
free cash flow yield | -0.02 - | 0.07 444.84% | -0.16 341.74% | -0.01 93.47% | 0.22 2,136.16% | -0.13 158.59% | -0.38 203.16% | 0.01 102.55% | -0.43 4,550.18% | -1.07 146.31% | -0.00 99.95% | |
graham net net | -1.42 - | -2.46 73.12% | 13.51 650.24% | 1.74 87.13% | 1.45 16.52% | 2.64 81.79% | 0.13 95.00% | 0.17 28.97% | 0.87 410.74% | -1.92 320.39% | -0.00 99.95% | |
graham number | 3.52 - | 6.63 88.42% | 36.85 456.13% | 8.90 75.85% | 7.00 21.30% | 11.98 71.03% | 7.56 36.87% | 4.16 45.00% | 6.28 50.92% | 6.59 4.98% | 0.00 99.99% | |
income quality | 0.53 - | -1.05 298.41% | 0.78 173.86% | 0.03 95.55% | -3.95 11,558.43% | 0.89 122.58% | 1.37 53.93% | -0.16 111.64% | 1.42 990.23% | 1.12 21.65% | 98.48 8,728.32% | |
intangibles to total assets | 0.19 - | 0.04 80.59% | 0.01 62.95% | 0.01 0.96% | 0.01 52.63% | 0.01 17.98% | 0.01 25.81% | 0.01 10.95% | 0.01 1.62% | 0.01 20.46% | 0.01 18.94% | |
interest coverage | -58.88 - | -61.12 3.80% | -19.17 68.63% | -35.28 84.03% | 50.22 - | |||||||
interest debt per share | 0.13 - | 0.10 22.06% | 0.20 102.58% | 0.05 76.87% | 0.32 - | 0.61 90.71% | 0.54 11.73% | 0.34 37.31% | 0.24 27.79% | 0.00 99.92% | ||
inventory turnover | ||||||||||||
invested capital | -0.09 - | -0.04 59.93% | 0.10 - | 0.54 431.39% | 0.50 7.79% | 0.24 51.44% | -0.21 186.84% | -0.29 39.86% | ||||
market cap | 450.53M - | 450.53M 0% | 179.38M 60.18% | 398.22M 121.99% | 784.59M 97.02% | 629.13M 19.81% | 376.74M 40.12% | 302.25M 19.77% | 277.76M 8.10% | 105.18M 62.13% | 114.40B 108,664.68% | |
net current asset value | -49.20M - | -84.75M 72.27% | 118.61M 239.95% | 67.50M 43.09% | 60.85M 9.84% | 119.25M 95.96% | 13.17M 88.96% | 15.15M 15.09% | 60.27M 297.74% | -109.54M 281.75% | -66.30M 39.47% | |
net debt to ebitda | 0.32 - | 2.12 568.64% | 1.84 12.79% | 1.89 2.21% | 3.98 111.06% | 3.26 18.13% | 1.47 54.73% | 3.63 145.97% | 2.24 38.32% | 1.73 22.56% | 0.49 71.55% | |
net income per share | -0.43 - | -0.87 100.16% | -4.12 374.21% | -1.63 60.50% | -1.16 28.66% | -2.03 75.11% | -2.26 11.06% | -0.71 68.40% | -1.26 76.42% | -1.48 17.72% | -0.00 100.00% | |
operating cash flow per share | -0.23 - | 0.91 497.13% | -3.19 450.28% | -0.06 98.24% | 4.58 8,274.23% | -1.81 139.54% | -3.10 70.95% | 0.11 103.68% | -1.86 1,728.21% | -1.69 9.18% | -0.00 99.95% | |
payables turnover | ||||||||||||
receivables turnover | 3.75 - | 2.71 27.73% | 10.37 282.81% | 6.50 37.26% | 7.06 8.62% | 613.42 8,583.65% | 4.42K 620.91% | 125.77 97.16% | 88.07 29.98% | 1.48 98.32% | 29.49 1,896.26% | |
research and ddevelopement to revenue | 12.26 - | 5.57 54.54% | 3.68 34.04% | 3.64 1.01% | 1.29 64.60% | 1.75 35.49% | 2.29 31.16% | 1.13 50.85% | 1.64 45.86% | 2.10 27.95% | 0.77 63.46% | |
return on tangible assets | -1.32 - | -0.43 67.33% | -0.18 57.78% | -0.30 64.88% | -0.11 63.62% | -0.19 70.57% | -0.30 62.08% | -0.09 69.42% | -0.24 159.13% | -0.38 57.14% | -0.00 99.24% | |
revenue per share | 0.03 - | 0.15 471.73% | 0.90 517.21% | 0.42 53.73% | 1.93 364.18% | 1.43 25.89% | 1.27 11.21% | 2.17 71.51% | 1.08 50.13% | 0.81 25.44% | 0.00 99.83% | |
roe | 0.34 - | 0.39 12.84% | -0.28 172.71% | -0.75 167.47% | -0.62 17.84% | -0.65 4.83% | -2.00 209.44% | -0.66 66.99% | -0.90 36.65% | 1.13 225.75% | 0.01 98.94% | |
roic | 0.37 - | 0.39 5.53% | -0.26 166.85% | -0.76 188.11% | -0.65 13.83% | -0.65 0.65% | -1.07 63.94% | -0.34 67.79% | -0.63 82.42% | 1.85 395.25% | -0.06 103.08% | |
sales general and administrative to revenue | 5.58 - | 1.29 76.91% | 1.63 26.41% | 1.32 18.87% | 0.36 72.94% | 0.56 57.53% | 0.64 13.56% | 0.36 43.86% | 0.56 56.78% | 0.81 43.20% | 0.30 63.20% | |
shareholders equity per share | -1.27 - | -2.25 77.38% | 14.67 752.20% | 2.17 85.23% | 1.88 13.17% | 3.14 67.04% | 1.13 64.11% | 1.08 4.27% | 1.39 29.10% | -1.30 193.62% | -0.00 99.95% | |
stock based compensation to revenue | 0.39 - | 0.11 71.80% | 0.52 374.52% | 0.67 29.84% | 0.16 76.52% | 0.28 80.00% | 0.33 17.13% | 0.15 55.66% | 0.19 28.46% | 0.25 30.45% | 0.08 65.75% | |
tangible asset value | -46.98M - | -81.24M 72.93% | 123.37M 251.86% | 75.78M 38.57% | 67.34M 11.13% | 128.48M 90.78% | 48.85M 61.98% | 47.69M 2.38% | 87.41M 83.30% | -87.58M 200.19% | -49.13M 43.91% | |
tangible book value per share | -1.35 - | -2.33 72.93% | 14.35 717.04% | 2.09 85.43% | 1.81 13.36% | 3.08 70.18% | 1.08 65.06% | 1.03 4.10% | 1.36 31.86% | -1.33 197.76% | -0.00 99.95% | |
working capital | 5.09M - | 55.69M 993.25% | 174.01M 212.47% | 152.38M 12.43% | 327.45M 114.89% | 347.57M 6.14% | 217.75M 37.35% | 223.09M 2.45% | 203.99M 8.56% | 84.49M 58.58% | 27.02M 68.02% |
All numbers in (except ratios and percentages)